Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Almonty Secures Strategic Foothold in US Critical Minerals Market

Dieter Jaworski by Dieter Jaworski
November 18, 2025
in Commodities, Industrial, Mergers & Acquisitions
0
Almonty Stock
0
SHARES
120
VIEWS
Share on FacebookShare on Twitter

Almonty Industries has established its first operational presence in the United States through the acquisition of the Gentung Browns Lake tungsten project in Montana. Company CEO Lewis Black described the move as a strategic entry into what he terms the “world’s most strategically important tungsten market.”

Addressing Critical Supply Chain Vulnerabilities

The timing of this acquisition coincides with significant supply pressures facing the U.S. defense sector. Chinese export restrictions and production quotas have created substantial tungsten shortages, directly impacting defense, aerospace, and advanced manufacturing industries. The Gentung Browns Lake project directly addresses these supply chain vulnerabilities by establishing domestic production capabilities.

The project’s strategic location offers substantial infrastructure advantages, including road access, proximity to power sources, secured water rights, and an existing mill site. These factors collectively support the company’s ambitious target to commence production in the second half of 2026.

Project Specifications and Operational Profile

The Montana project brings considerable resources to Almonty’s asset portfolio:

  • Total Mineral Resources: 7.53 million tonnes grading 0.315% WO₃
  • Planned Annual Production: Approximately 140,000 metric tonne units
  • Tungsten Recovery Rate: Exceeding 90%
  • Mining Method: Underground room-and-pillar development

This acquisition solidifies Almonty’s position as a leading Western tungsten supplier for critical U.S. industries that depend on reliable access to this strategic metal.

Global Operations and Market Positioning

“By entering the United States, we’re expanding into the world’s most strategically important tungsten market,” stated CEO Black, noting that this market is actively rebuilding domestic supply chains and reducing dependence on Chinese sources.

Should investors sell immediately? Or is it worth buying Almonty?

The Montana acquisition complements Almonty’s existing global operations:

  • Sangdong Mine (South Korea): Nearing completion
  • Panasqueira Mine (Portugal): Operating at stable production levels
  • Spanish Projects: Demonstrating renewed growth potential

Analyst Confidence and Price Targets

Market analysts have responded positively to Almonty’s strategic moves. D.A. Davidson recently reaffirmed its buy recommendation for Almonty with a $12 price target, citing improved tungsten market conditions and Chinese export restrictions as key growth drivers.

The MarketBeat consensus price target stands at $9.83, indicating significant upside potential from current trading levels. The analyst community widely recognizes Almonty’s unique positioning within the global tungsten supply chain.

Geopolitical Context and Strategic Importance

Global tungsten supply faces increasing constraints due to geopolitical tensions and Chinese production limitations. Almonty’s Montana acquisition aligns with U.S. government initiatives aimed at strengthening critical mineral independence.

The domestic location eliminates international shipping complexities and provides supply chain security for U.S.-based tungsten consumers. This positioning becomes increasingly valuable as defense contractors actively seek reliable non-Chinese tungsten sources.

The acquisition establishes Almonty as a key player in rebuilding American tungsten production capacity—a strategic position that serves both national security interests and shareholder value creation.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from February 7 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock
Gaming & Metaverse

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Next Post
Omv Stock

OMV Shares Face Conflicting Signals as Management and Analysts Clash

Adobe Stock

Adobe Shares Plunge to New Depths Amid Institutional Sell-Off

Volatus Aerospace Stock

Volatus Aerospace Secures Strategic Funding and Technology in Defense Push

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com